Should I buy or sell Apollo Medical stock right now?

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Apollo Medical in the last year. There are currently 2 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" AMEH shares. View AMEH analyst ratings or view top-rated stocks .

What is Apollo Medical's stock price target for 2024?

5 equities research analysts have issued 1 year price targets for Apollo Medical's shares. Their AMEH share price targets range from $41.00 to $60.00. On average, they predict the company's share price to reach $47.00 in the next year. This suggests a possible upside of 26.1% from the stock's current price. View analysts price targets for AMEH or view top-rated stocks among Wall Street analysts .

How have AMEH shares performed in 2024?

Apollo Medical's stock was trading at $38.30 at the beginning of the year. Since then, AMEH shares have decreased by 2.7% and is now trading at $37.27. View the best growth stocks for 2024 here .

When is Apollo Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 27th 2024. View our AMEH earnings forecast .

How can I listen to Apollo Medical's earnings call?

Apollo Medical will be holding an earnings conference call on Tuesday, February 27th at 5:30 PM Eastern. Interested parties can register for or listen to the call using this link .

How were Apollo Medical's earnings last quarter?

Apollo Medical Holdings, Inc. (NASDAQ:AMEH) issued its quarterly earnings data on Thursday, November, 4th. The company reported $0.69 EPS for the quarter, beating the consensus estimate of $0.34 by $0.35. The company earned $227.12 million during the quarter. Apollo Medical had a net margin of 3.56% and a trailing twelve-month return on equity of 9.90%. During the same period last year, the company posted $0.45 EPS.

What ETFs hold Apollo Medical's stock?

ETFs with the largest weight of Apollo Medical (NASDAQ:AMEH) stock in their portfolio include Fidelity Digital Health ETF (FDHT) , Invesco S&P SmallCap Health Care ETF (PSCH) , SPDR S&P Health Care Services ETF (XHS) and Syntax Stratified SmallCap ETF (SSLY) . iShares U.S. Healthcare Providers ETF (IHF) .

What guidance has Apollo Medical issued on next quarter's earnings?

Apollo Medical issued an update on its FY 2023 earnings guidance on Tuesday, January, 30th. The company provided earnings per share guidance of 1.100-1.200 for the period, compared to the consensus EPS estimate of 1.200. The company issued revenue guidance of $1.3 billion-$1.4 billion, compared to the consensus revenue estimate of $1.4 billion.

What is Thomas Lam's approval rating as Apollo Medical's CEO?

15 employees have rated Apollo Medical Chief Executive Officer Thomas Lam on Glassdoor.com . Thomas Lam has an approval rating of 43% among the company's employees. This puts Thomas Lam in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies. 28.0% of employees surveyed would recommend working at Apollo Medical to a friend.

What other stocks do shareholders of Apollo Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Apollo Medical investors own include PayPal (PYPL) , SEA (SE) , Mastercard (MA) , NVIDIA (NVDA) , Walt Disney (DIS) , Lululemon Athletica (LULU) , Enphase Energy (ENPH) , Main Street Capital (MAIN) , Block (SQ) and Exxon Mobil (XOM) .

Who are Apollo Medical's major shareholders?

Apollo Medical's stock is owned by many different retail and institutional investors. Top institutional investors include Dimensional Fund Advisors LP (1.32%), SteelPeak Wealth LLC (1.16%), Charles Schwab Investment Management Inc. (0.59%), Atria Wealth Solutions Inc. (0.41%), Principal Financial Group Inc. (0.38%) and Fort Washington Investment Advisors Inc. OH (0.30%). Insiders that own company stock include Albert Waichow Young , Brandon Sim , Linda Marsh and Physicians Of Californi Allied. View institutional ownership trends .

How do I buy shares of Apollo Medical?

Shares of AMEH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

Does Apollo Medical have any subsidiaries?

The following companies are subsidiares of Apollo Medical: Standard Aero (alliance) Inc.. Read More

NASDAQ:AMEH

Apollo Medical (AMEH) Stock Price, News & Analysis

$37.27

+0.56 (+1.53%)

(As of 02/9/2024 08:55 PM ET)

Compare

Today's Range: $36.40
▼
$37.46
50-Day Range: $32.96
▼
$40.17
52-Week Range: $28.86
▼
$40.81

Volume: 137,100 shs
Average Volume: 150,386 shs
Market Capitalization: $2.17 billion

P/E Ratio: 37.27
Dividend Yield: N/A
Price Target: $47.00

Get Apollo Medical alerts:

Apollo Medical MarketRank™ Stock Analysis

Analyst Rating: Moderate Buy
2.60 Rating Score
Upside/Downside: 26.1% Upside
$47.00 Price Target
Short Interest: Bearish
5.68% of Float Sold Short
Dividend Strength: N/A
Sustainability: -0.69
Upright™ Environmental Score
News Sentiment: 0.76
Based on 5 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: 19.49%
From $1.18 to $1.41 Per Share

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.37 out of 5 stars

Medical Sector

135th out of 922 stocks

Management Consulting Services Industry

5th out of 17 stocks

3.3

Analyst's Opinion

Consensus Rating
Apollo Medical has received a consensus rating of Moderate Buy. The company's average rating score is 2.60, and is based on 3 buy ratings, 2 hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $47.00, Apollo Medical has a forecasted upside of 26.1% from its current price of $37.27.
Amount of Analyst Coverage
Apollo Medical has only been the subject of 2 research reports in the past 90 days.

1.0

Short Interest

Percentage of Shares Shorted
5.68% of the float of Apollo Medical has been sold short.
Short Interest Ratio / Days to Cover
Apollo Medical has a short interest ratio ("days to cover") of 14, which indicates bearish sentiment.
Change versus previous month
Short interest in Apollo Medical has recently decreased by 4.03%, indicating that investor sentiment is improving.

0.0

Dividend Strength

Dividend Yield
Apollo Medical does not currently pay a dividend.
Dividend Growth
Apollo Medical does not have a long track record of dividend growth.

4.3

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
Apollo Medical has received a 64.92% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is driven by its "Health care management software" and "Management consulting for medical care" products. See details.
Environmental Sustainability
The Environmental Impact score for Apollo Medical is -0.69.

2.6

News and Social Media Coverage

News Sentiment
Apollo Medical has a news sentiment score of 0.76. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.92 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 5 news articles for Apollo Medical this week, compared to 1 article on an average week.
Search Interest
Only 1 people have searched for AMEH on MarketBeat in the last 30 days. This is a decrease of -67% compared to the previous 30 days.
MarketBeat Follows
2 people have added Apollo Medical to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.

0.0

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Apollo Medical insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 8.46% of the stock of Apollo Medical is held by insiders.
Percentage Held by Institutions
Only 35.88% of the stock of Apollo Medical is held by institutions.

3.1

Earnings and Valuation

Earnings Growth
Earnings for Apollo Medical are expected to grow by 19.49% in the coming year, from $1.18 to $1.41 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Apollo Medical is 37.27, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 123.39.
Price to Earnings Ratio vs. Sector
The P/E ratio of Apollo Medical is 37.27, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 111.08.
Price to Earnings Growth Ratio
Apollo Medical has a PEG Ratio of 2.30. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
Apollo Medical has a P/B Ratio of 3.88. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Apollo Medical Stock (NASDAQ:AMEH)

Apollo Medical Holdings, Inc., a physician-centric technology-powered healthcare company, provides medical care services in the United States. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients in California. The company was incorporated in 1985 and is headquartered in Alhambra, California.

AMEH Stock Price History

30 days | 90 days | 365 days | Advanced Chart

AMEH Stock News Headlines

February 8, 2024 | msn.com

Apollo PAT up 60% on robust growth across businesses

February 8, 2024 | investing.com

Apollo Medical Holdings Inc (AMEH)

February 12, 2024 | Behind the Markets (Ad)

Laser breakthrough could send stock soaring 2,467%

Laser breakthrough could send stock soaring 2,476% Whenever the military develops a breakthrough technology, timely investors could see groundbreaking returns. General Dynamics returned 8,990%... Boeing soared 4,238%... L3Harris shot up 1,628%...

February 8, 2024 | msn.com

Apollo Hospitals Q3 Results: Net profit rises 60% to Rs 245 crore

February 8, 2024 | finance.yahoo.com

An excellent week for Apollo Medical Holdings, Inc.'s (NASDAQ:AMEH) institutional owners who own 47% as one-year returns inch higher

February 5, 2024 | americanbankingnews.com

Contrasting Apollo Medical (NASDAQ:AMEH) & Leafbuyer Technologies (OTCMKTS:LBUY)

January 31, 2024 | finance.yahoo.com

Apollo Medical Holdings, Inc. Schedules 2023 Fourth Quarter and Full Year Financial Results Release and Conference Call

January 30, 2024 | msn.com

ApolloMed and BASS partner to enhance value-based healthcare

February 12, 2024 | Porter and Company (Ad)

Public Service Announcement: New National Emergency Incoming

Americans urged to share this new documentary with their friends and family before this looming event triggers a new national crisis…

January 29, 2024 | finanznachrichten.de

Apollo Medical Holdings, Inc.: ApolloMed and BASS Medical Group to Forge a Value-Based Healthcare Partnership

January 24, 2024 | markets.businessinsider.com

Apollo Medical Holdings Names Brandon Sim CEO, Chan Basho COO

January 24, 2024 | finance.yahoo.com

Apollo Medical Holdings, Inc. Announces Planned Corporate Rebrand as Astrana Health

January 24, 2024 | finance.yahoo.com

Apollo Medical Holdings, Inc. Announces Leadership Transitions

January 18, 2024 | msn.com

Apollo Hospitals Share Price Target 2024: Nomura BULLISH on APOLLOHOSP stock - Check details

January 16, 2024 | seekingalpha.com

Apollo Medical Holdings: Good Company, Not Quite A Hold

January 11, 2024 | msn.com

Apollo Hospital partners with LifeSigns, inducts advanced remote patient monitoring system

January 7, 2024 | markets.businessinsider.com

Analysts Offer Insights on Healthcare Companies: Xtant Medical Holdings (XTNT), Apollo Medical Holdings (AMEH) and Atricure (ATRC)

January 5, 2024 | benzinga.com

Apollo Medical Hlgs Stock (NASDAQ:AMEH), Quotes and News Summary

January 2, 2024 | markets.businessinsider.com

BTIG Reaffirms Their Buy Rating on Apollo Medical Holdings (AMEH)

January 2, 2024 | msn.com

Apollo secures funds to advance pipeline programmes

December 23, 2023 | msn.com

Truist Securities Initiates Coverage of Apollo Medical Holdings (AMEH) with Hold Recommendation

December 22, 2023 | benzinga.com

Apollo Medical Hlgs Stock (NASDAQ:AMEH) Dividends: History, Yield and Dates

December 18, 2023 | finance.yahoo.com

Apollo Medical Holdings, Inc. Announces Grant of Inducement Awards Pursuant to Nasdaq Listing Rule 5635(c)(4)

November 14, 2023 | finance.yahoo.com

ELV or AMEH: Which Is the Better Value Stock Right Now?

November 13, 2023 | finance.yahoo.com

Apollo Medical Holdings, Inc. to Participate in Upcoming Investor Conference

November 9, 2023 | morningstar.com

Apollo Medical Holdings Inc AMEH

November 9, 2023 | markets.businessinsider.com

Apollo Medical Holdings: Strong Q3 Results and Strategic Growth Initiatives Reinforce Buy Rating

See More Headlines

Receive AMEH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Apollo Medical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 11/04/2021
Today: 2/12/2024
Next Earnings (Confirmed): 2/27/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Management consulting services
Sub-Industry: N/A
Current Symbol: NASDAQ:AMEH
CUSIP: N/A
CIK: 1083446
Web: www.apollomed.net
Phone: (626) 282-0288
Fax: 818-839-5190
Employees: 1,362
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $47.00
High Stock Price Target: $60.00
Low Stock Price Target: $41.00
Potential Upside/Downside: +26.1%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.60
Research Coverage: 5 Analysts

Profitability

EPS (Most Recent Fiscal Year): $1.00
Trailing P/E Ratio: 37.27
Forward P/E Ratio: 31.58
P/E Growth: 2.3
Net Income: $45.17 million
Net Margins: 3.56%
Pretax Margin: 7.48%
Return on Equity: 9.90%
Return on Assets: 5.51%

Debt

Debt-to-Equity Ratio: 0.35
Current Ratio: 2.35
Quick Ratio: 2.35

Sales & Book Value

Annual Sales: $1.14 billion
Price / Sales: 1.90
Cash Flow: $1.26 per share
Price / Cash Flow: 29.69
Book Value: $9.60 per share
Price / Book: 3.88

Miscellaneous

Outstanding Shares: 58,280,000
Free Float: 53,353,000
Market Cap: $2.17 billion
Optionable: Optionable
Beta: 1.04

Social Links

7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

Dr. Kenneth T. Sim M.D. (Age 70)
Executive Chairman
Comp: $1.49M
Dr. Thomas S. Lam M.D. (Age 75)
M.P.H., President, Co-CEO & Director
Comp: $1.49M
Mr. Brandon Sim (Age 30)
Co-Chief Executive Officer
Comp: $1.73M
Mr. Chandan Basho (Age 42)
Chief Strategy Officer, CFO & Corporate Secretary
Comp: $581.42k
Dr. WaiChow Young M.D. (Age 77)
Chief Administrative Officer
Comp: $573.67k
Mr. John Vong (Age 51)
Chief Accounting Officer
Dr. Jeremy R. Jackson M.D.
Chief Quality Officer
Mr. Neil Ahuja
President of Provider Solutions
Yubin Park
Chief Data & Analytics Officer
Dr. Carlos Palacios M.D.
Chief Medical Officer for Texas

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions

AMEH Stock Analysis - Frequently Asked Questions

Should I buy or sell Apollo Medical stock right now?: 5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Apollo Medical in the last year. There are currently 2 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" AMEH shares.
View AMEH analyst ratings or view top-rated stocks.
What is Apollo Medical's stock price target for 2024?: 5 equities research analysts have issued 1 year price targets for Apollo Medical's shares. Their AMEH share price targets range from $41.00 to $60.00. On average, they predict the company's share price to reach $47.00 in the next year. This suggests a possible upside of 26.1% from the stock's current price.
View analysts price targets for AMEH or view top-rated stocks among Wall Street analysts.
How have AMEH shares performed in 2024?: Apollo Medical's stock was trading at $38.30 at the beginning of the year. Since then, AMEH shares have decreased by 2.7% and is now trading at $37.27.
View the best growth stocks for 2024 here.
When is Apollo Medical's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 27th 2024.
View our AMEH earnings forecast.
How can I listen to Apollo Medical's earnings call?: Apollo Medical will be holding an earnings conference call on Tuesday, February 27th at 5:30 PM Eastern. Interested parties can register for or listen to the call using this link.
How were Apollo Medical's earnings last quarter?: Apollo Medical Holdings, Inc. (NASDAQ:AMEH) issued its quarterly earnings data on Thursday, November, 4th. The company reported $0.69 EPS for the quarter, beating the consensus estimate of $0.34 by $0.35. The company earned $227.12 million during the quarter. Apollo Medical had a net margin of 3.56% and a trailing twelve-month return on equity of 9.90%. During the same period last year, the company posted $0.45 EPS.
What ETFs hold Apollo Medical's stock?: ETFs with the largest weight of Apollo Medical (NASDAQ:AMEH) stock in their portfolio include Fidelity Digital Health ETF (FDHT), Invesco S&P SmallCap Health Care ETF (PSCH), SPDR S&P Health Care Services ETF (XHS) and Syntax Stratified SmallCap ETF (SSLY).iShares U.S. Healthcare Providers ETF (IHF).

What guidance has Apollo Medical issued on next quarter's earnings?: Apollo Medical issued an update on its FY 2023 earnings guidance on Tuesday, January, 30th. The company provided earnings per share guidance of 1.100-1.200 for the period, compared to the consensus EPS estimate of 1.200. The company issued revenue guidance of $1.3 billion-$1.4 billion, compared to the consensus revenue estimate of $1.4 billion.
What is Thomas Lam's approval rating as Apollo Medical's CEO?: 15 employees have rated Apollo Medical Chief Executive Officer Thomas Lam on Glassdoor.com. Thomas Lam has an approval rating of 43% among the company's employees. This puts Thomas Lam in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies. 28.0% of employees surveyed would recommend working at Apollo Medical to a friend.
What other stocks do shareholders of Apollo Medical own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Apollo Medical investors own include PayPal (PYPL), SEA (SE), Mastercard (MA), NVIDIA (NVDA), Walt Disney (DIS), Lululemon Athletica (LULU), Enphase Energy (ENPH), Main Street Capital (MAIN), Block (SQ) and Exxon Mobil (XOM).
Who are Apollo Medical's major shareholders?: Apollo Medical's stock is owned by many different retail and institutional investors. Top institutional investors include Dimensional Fund Advisors LP (1.32%), SteelPeak Wealth LLC (1.16%), Charles Schwab Investment Management Inc. (0.59%), Atria Wealth Solutions Inc. (0.41%), Principal Financial Group Inc. (0.38%) and Fort Washington Investment Advisors Inc. OH (0.30%). Insiders that own company stock include Albert Waichow Young, Brandon Sim, Linda Marsh and Physicians Of Californi Allied.
View institutional ownership trends.
How do I buy shares of Apollo Medical?: Shares of AMEH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.
Does Apollo Medical have any subsidiaries?: The following companies are subsidiares of Apollo Medical: Standard Aero (alliance) Inc..
Read More

This page (NASDAQ:AMEH) was last updated on 2/12/2024 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial